ES2074530T3 - Cicloalquilenazoles, procedimiento para su produccion, preparaciones farmaceuticas que los contienen, y su aplicacion para la preparacion de medicamentos. - Google Patents

Cicloalquilenazoles, procedimiento para su produccion, preparaciones farmaceuticas que los contienen, y su aplicacion para la preparacion de medicamentos.

Info

Publication number
ES2074530T3
ES2074530T3 ES90250201T ES90250201T ES2074530T3 ES 2074530 T3 ES2074530 T3 ES 2074530T3 ES 90250201 T ES90250201 T ES 90250201T ES 90250201 T ES90250201 T ES 90250201T ES 2074530 T3 ES2074530 T3 ES 2074530T3
Authority
ES
Spain
Prior art keywords
medicines
production
application
cyclloalkyleneazoles
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90250201T
Other languages
English (en)
Inventor
Rolf Dr Bohlmann
Peter Dr Strehlke
David Dr Henderson
Martin Dr Schneider
Yukishige Dr Nishino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of ES2074530T3 publication Critical patent/ES2074530T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

EL INVENTO SE REFIERE A UN CICLOALQUILENOAZOL DE FORMULA (I); RESEÑA LA FUERTE ACTIVIDAD INHIBIDORA DE AROMATASA DEL COMPUESTO DE FORMULA (I) Y DESCRIBE LA APLICACION DEL COMPUESTO DE FORMULA (I) PARA LA PRODUCCION DE MEDICAMENTOS. EL RESTO DE FORMULA (II) ES UN SISTEMA CARBOCICLICO O CARBOPOLICICLICO QUE LLEVA UN SUSTITUYENTE ALQUILO; X UN GRUPO -HC =CHGENO O AZUFRE E Y Y Z UN GRUPO =CH-, CH O UN NITROGENO.
ES90250201T 1989-08-04 1990-08-06 Cicloalquilenazoles, procedimiento para su produccion, preparaciones farmaceuticas que los contienen, y su aplicacion para la preparacion de medicamentos. Expired - Lifetime ES2074530T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3926365A DE3926365A1 (de) 1989-08-04 1989-08-04 Cycloalkylenazole, verfahren zu deren herstellung, pharmazeutische praeparate, die diese enthalten sowie ihre verwendung zur herstellung von arzneimitteln

Publications (1)

Publication Number Publication Date
ES2074530T3 true ES2074530T3 (es) 1995-09-16

Family

ID=6386820

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90250201T Expired - Lifetime ES2074530T3 (es) 1989-08-04 1990-08-06 Cicloalquilenazoles, procedimiento para su produccion, preparaciones farmaceuticas que los contienen, y su aplicacion para la preparacion de medicamentos.

Country Status (19)

Country Link
US (3) US5135937A (es)
EP (1) EP0411735B1 (es)
JP (1) JP3207417B2 (es)
CN (1) CN1024345C (es)
AT (1) ATE122662T1 (es)
AU (1) AU634266B2 (es)
CA (1) CA2022682C (es)
DD (1) DD296917A5 (es)
DE (2) DE3926365A1 (es)
DK (1) DK0411735T3 (es)
ES (1) ES2074530T3 (es)
FI (1) FI920425A0 (es)
HU (2) HUT59911A (es)
IE (1) IE902843A1 (es)
IL (1) IL95279A (es)
NO (1) NO301115B1 (es)
PT (1) PT94884B (es)
WO (1) WO1991001975A1 (es)
ZA (1) ZA906150B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5112845A (en) * 1986-03-07 1992-05-12 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US5352795A (en) * 1986-03-07 1994-10-04 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
TW224461B (es) * 1990-09-18 1994-06-01 Ciba Geigy Ag
DE4107038A1 (de) * 1991-03-01 1992-09-03 Schering Ag Triheteroarylmethane, verfahren zu deren herstellung, pharmazeutische praeparate die diese enthalten sowie ihre verwendung zur herstellung von arzneimitteln
DE4120107A1 (de) * 1991-06-14 1992-12-17 Schering Ag Bicyclisch substituierte vinylimidazole, -triazole und -tetrazole
DE4435368A1 (de) * 1994-09-22 1996-03-28 Schering Ag Verwendung von Aromatasehemmern zur Herstellung eines Arzneimittels zur Behandlung eines relativen Androgenmangels beim Mann
ZA9510926B (en) 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
BR0013272B1 (pt) * 1999-08-13 2013-10-15 Uso de um inibidor de aromatase esteroidal
KR100917698B1 (ko) 2005-07-06 2009-09-21 시코르, 인크. 레트로졸의 제조를 위한 개선된 방법
CN100425621C (zh) * 2006-07-06 2008-10-15 云南大学 甾体咪唑盐类化合物及其制备方法
CN116925001B (zh) * 2023-07-26 2025-09-30 陕西师范大学 一种抗乳腺癌药物来曲唑类似物的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4609666A (en) * 1984-06-18 1986-09-02 Eli Lilly And Company Aromatase inhibiting derivatives of α,α-bis(4-halophenyl)methyltetrazoles and triazoles
JPS62149666A (ja) * 1985-12-25 1987-07-03 Shionogi & Co Ltd Ｎ−ビニルアゾ−ル類
US4749713A (en) * 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles

Also Published As

Publication number Publication date
IL95279A (en) 1995-03-30
CA2022682A1 (en) 1991-02-05
JPH05501104A (ja) 1993-03-04
EP0411735B1 (de) 1995-05-17
HU9200324D0 (en) 1992-04-28
US5280035A (en) 1994-01-18
AU6019490A (en) 1991-02-07
FI920425A7 (fi) 1992-01-30
JP3207417B2 (ja) 2001-09-10
ZA906150B (en) 1991-05-29
CN1049157A (zh) 1991-02-13
CN1024345C (zh) 1994-04-27
EP0411735A1 (de) 1991-02-06
HUT59911A (en) 1992-07-28
FI920425A0 (fi) 1992-01-30
DK0411735T3 (da) 1995-10-16
IL95279A0 (en) 1991-06-30
DE3926365A1 (de) 1991-02-07
US5135937A (en) 1992-08-04
DD296917A5 (de) 1991-12-19
NO301115B1 (no) 1997-09-15
WO1991001975A1 (de) 1991-02-21
IE902843A1 (en) 1991-02-27
DE59009084D1 (de) 1995-06-22
CA2022682C (en) 1997-01-21
NO920432D0 (no) 1992-02-03
HU217126B (hu) 1999-11-29
AU634266B2 (en) 1993-02-18
PT94884B (pt) 1997-04-30
US5411982A (en) 1995-05-02
NO920432L (no) 1992-02-03
PT94884A (pt) 1991-04-18
ATE122662T1 (de) 1995-06-15

Similar Documents

Publication Publication Date Title
PT83647B (pt) Processo para a preparacao de novos derivados de benzimidazole com actividade farmacologica e de composicoes farmaceuticas que os contem
ES557179A0 (es) Sistema para la administracion transdermica de un farmaco seleccionado del grupo formado por fentanil y sus derivados analgesicamente eficaces
ES2046196T3 (es) Derivados de azacicloalcanos, promotores de absorcion que contienen los derivados como ingrediente eficaz y preparaciones externas que contienen los promotores de absorcion.
ES2058527T3 (es) Derivados de pirimidina condensados procedimiento y compuestos intermedios para su preparacion y composiciones farmaceuticas que los contienen.
ES2054860T3 (es) Nuevos derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion, asi como a su utilizacion como medicamentos.
ES2074530T3 (es) Cicloalquilenazoles, procedimiento para su produccion, preparaciones farmaceuticas que los contienen, y su aplicacion para la preparacion de medicamentos.
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
ES2142798T3 (es) Derivados de 3-amido pirazol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES480109A1 (es) Procedimkiento para la preparacion de derivados de imidazo- lidina.
ES2079719T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su utilizacion y agentes que los contienen en calidad de anticoagulantes.
ES8401977A1 (es) Procedimiento para preparar nuevos compuestos de cefem.
PT99055A (pt) Processo para a preparacao de novas aminas alquil-heterociclicas e de composicoes farmaceuticas que as contem
ES2032394T3 (es) Procedimiento para preparar derivados de tienoimidazol sustituidos.
PT82097B (pt) Processo para a preparacao de derivados de labdano e de composicoes farmaceuticas que os contem
MX9304793A (es) Glicanas de actividad inmunoestimulante.
ES2086341T3 (es) Derivados de aminoacidos con propiedades inhibidoras de la renina, procedimiento para su preparacion, agentes que los contienen y su utilizacion.
PT81893B (pt) Processo para a preparacao de derivados de labdano e de composicoes farmaceuticas que os contem
ES2098505T3 (es) Nuevos derivados de la talidomida, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES8801803A1 (es) Procedimiento para preparar derivados de cinalina.
ES2056184T3 (es) Derivados del 2-amino-6-cloro-4-nitro-fenol, procedimientos para su preparacion y colorantes para el cabello que contienen dichos derivados como colorantes nitrados directos.
PT82512B (pt) Processo para a preparacao de derivados de quinolilglicinamidas com actividade psicotropica e de composicoes farmaceuticas que os contem
ES2032752T3 (es) Procedimiento de preparacion de derivados de la 1-bencenosulfonil-2-oxo-5-alcoxi-pirrolidina.
ES476917A1 (es) Un procedimiento para la preparacion de derivados de acido -4-piridon-3-carboxilico.
ES2043696T3 (es) Derivados de prostaglandina e1 (derivados-pge1) como substancias activas farmaceuticas y medicamentos que contienen estos compuestos, especialmente para aplicacion transcutanea.
MX9301235A (es) DERIVADOS 1,4-DIOXINO(2,3-B)PIRIDINA. á

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 411735

Country of ref document: ES